MétaCan
Menu
← Back to cohort
Record W7117258015 · doi:10.1002/alz70856_101554

Exploring Blood‐Based Biomarkers in a Comparative Study of Amyloid‐Negative and Amyloid‐Positive Clinical Alzheimer's Syndrome

2025· article· en· W7117258015 on OpenAlexaff
Durjoy Lahiri, Jennifer G Cooper, Bruna Seixas Lima, Carlos Roncero, Cheryl L. Wellington, Mari L. DeMarco, Howard Chertkow

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsQuebec - Clinical Research Organization in CancerOccupational Cancer Research CentreProvidence Health CareMcGill UniversityBaycrest HospitalUniversity of TorontoKingston Health Sciences CentreUniversity of British ColumbiaQueen's University
Fundersnot available
KeywordsBiomarkerDiseasePathophysiologyBiomarker discoveryMEDLINE

Abstract

fetched live from OpenAlex

BACKGROUND: It has been documented, 25-33% of individuals clinically diagnosed with Alzheimer's syndrome, commonly referred to as the Alzheimer's phenotype, do not exhibit amyloid plaques in the brain upon autopsy. While non-Alzheimer pathologies are suspected to contribute to misdiagnosis and cognitive decline observed in these patients, pathological distinctions between amyloid-positive (Aβ+) and amyloid-negative (Aβ-) individuals remain poorly understood. Further investigation into these differences using blood-based biomarkers may provide valuable insights into the underlying pathophysiology of the amyloid-negative subgroup. Our objective was to compare blood-based biomarkers between Aβ- and Aβ+ subgroups diagnosed with clinical Alzheimer's syndrome. METHOD: Participants were recruited from the screening phase of clinical trials investigating anti-amyloid agents. A retrospective chart review was conducted to collect demographic, clinical, imaging, biomarker, and neuropsychological data. Amyloid-beta (Aβ) status was assessed through cerebrospinal fluid (CSF) analysis using the Roche-Elecsys β-Amyloid (1-42) CSF II assay or positron emission tomography (PET) imaging. Plasma samples were analyzed on the Quanterix Simoa HD-X platform, employing neurology-4-plex-E, p-tau-181, p-tau-217, and TDP-43 assays. Statistical analyses were performed using the Mann-Whitney U test for continuous variables and Fisher's exact test for categorical variables to compare group differences. RESULT: Of n = 45 patients, n = 25 (56%) were classified as Aβ+, and n = 20 (44%) were classified as Aβ-. No significant differences were found between groups in terms of age, sex, duration of illness or cognitive presentation. Groupwise analysis revealed significantly elevated concentrations of phosphorylated tau (p-tau) proteoforms in the Aβ+ group, including p-tau 181 (4.32 vs 2.93 pg/mL, p = 0.0058) and p-tau 217 (1.36 vs 0.46 pg/mL, p <0.0001), as well as glial fibrillary acidic protein (GFAP) (223 vs 123 pg/mL, p = 0.0265) and neurofilament light chain (NfL) (31.8 vs 19.1 pg/mL, p = 0.0068), relative to the Aβ- group. Although no significant differences were observed for Aβ42/40 (0.0548 vs 0.0567 pg/mL, p = 0.1466) or TDP-43 (2219 vs 359 pg/mL, p = 0.0607), the Aβ- group exhibited markedly higher TDP-43 concentrations compared to the Aβ+ group. CONCLUSION: These findings highlight distinct biomarker profiles between Aβ+ and Aβ- individuals, offering insights into the pathophysiology of clinical Alzheimer's syndrome.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.138
GPT teacher head0.389
Teacher spread0.252 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicDementia and Cognitive Impairment Research→French-language works237,207→